Company type | Non-Profit |
---|---|
Founded | 1976 in New York City |
Founder | Dr. Eugene Thiessen |
Headquarters | 1501 Broadway, Suite 704A New York, NY 10036 |
Key people | Jacqueline Reinhard (Executive Director) Didi Lacher (President) |
Website |
SHARE is a "highly regarded New York City peer support" organization of women affected by breast or ovarian cancer. [1] SHARE is a professionally managed volunteer organization. Trained volunteers and staff who are breast or ovarian cancer survivors operate telephone hotlines in English, Spanish and ten other languages, lead support groups, and offer an array of educational services in 18 sites and in every borough of New York City. [2] [3] SHARE does not charge for any of its services, and has been praised for "their extensive outreach programs to underserved communities in New York City." [4] The organization cooperates with several major hospitals in the New York City area. [5]
1976: SHARE was started by cancer specialist Dr. Eugene Thiessen as an informal support group for 12 women with breast cancer. [6]
1978: SHARE incorporated as a not-for-profit organization in New York State. [7]
1987[ citation needed ]: LatinaSHARE was started to provide support, information, education and advocacy opportunities for people who feel more comfortable communicating in Spanish.
1995: SHARE began offering services for women with ovarian cancer. [7]
2007: SHARE expanded services specifically for women with metastatic breast cancer. [7]
2008: The New York Department of Health issued this statement [8] while announcing a grant to SHARE and nine other community-based breast cancer education, counseling, outreach and support services:
Support groups, education, counseling and related activities can help reduce stress experienced by breast cancer patients, improve their ability to cope and deal with the uncertainties, challenges and life complications that accompany the disease and also enable them to make more effective use of health services. Breast cancer survivors may have a myriad of clinical and psychosocial needs, and support services have been shown to improve their quality of life.
A philosophy of peer support guides SHARE activities. Its web site states, "We are breast and ovarian cancer survivors and we're here to help you." A survivor and later volunteer published this first person account of the peer support process:
"I was scared to death," she says, "because I had to make so many major decisions about breast reconstruction, hormonal treatments, possible chemotherapy, and everything else. My knowledge of breast cancer was only that it happened to other women, not me." But communicating her fears, and realizing that other women had similar worries and stories to share, was empowering. "I know that this sounds hokey," Nancy says, "but when I sat in that room, for the first time I felt like I was going to live and that I was not alone. Sitting in a room full of women who were dealing with the same issues, who were also scared to death, gave me strength." Likewise, Nancy says, her communication with a peer match counselor—a volunteer from the SHARE hotline who also had DCIS—was inspiring: "She shared her story with me, and it gave me hope." [9]
The benefits of emotional support to women with breast cancer have been acknowledged in the medical literature. [10]
According to the United Nations World Health Organization, more than 500,000 people worldwide die from breast cancer every year, and breast cancer is the leading cause of cancer deaths among women worldwide. [11] Recognizing the need for women to help each other to deal with the impact of this disease, SHARE volunteers have assisted in creating similar peer-support organizations in Israel and the Czech Republic. [12]
SHARE seeks to play an active role in shaping the public policy agenda related to breast and ovarian cancer. [13] Breast cancer is the second leading cause of cancer-related death among women in New York State, and nearly 14,000 New York State women are newly diagnosed with breast cancer each year, and approximately 3,000 die from the disease annually. [8] SHARE hopes to reduce these numbers by advocating for health resources and awareness.
SHARE sponsors "A Second Helping of Life," an annual event since 2003, in which many of the top female chefs in New York City converge in a giant tasting party to benefit SHARE. [14] [15] Among the chefs participating in 2009 were:
Rebecca Charles (Pearl Oyster Bar), Anita Lo (Annisa & Rickshaw Dumpling Bar), Gina DePalma (Babbo) and Alex Guarnaschelli (Butter). Guest Chefs will include Dana Cowin of Food & Wine Magazine, Ruth Reichel of Gourmet, and stars of the stage and screen such as broadcasting mavens including Samantha Mathis, Robin Mattson Ellen Parker, Bravo "Top Chef Masters" host, Kelly Choi, and TV personality Sara Moulton. [16]
In 2009, Chef Lo competed in the TV show Top Chef Masters with SHARE as the named beneficiary of her $20,000 winnings. [17]
Breast cancer is a cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, milk rejection, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.
Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by surgeon Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research. The center is usually called Roswell Park in short. The center, which conducts clinical research on cancer as well as the development new drugs, provides advanced treatment for all forms of adult and pediatric cancer, and serves as a member of the National Comprehensive Cancer Network. Roswell Park Comprehensive Cancer Center is as of 2019, the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center".
Bevacizumab, sold under the brand name Avastin among others, is a monoclonal antibody medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow injection into a vein (intravenous) and used for colon cancer, lung cancer, ovarian cancer, glioblastoma, and renal-cell carcinoma. In many of these diseases it is used as a first-line therapy. For age-related macular degeneration it is given by injection into the eye (intravitreal).
The Canadian Cancer Society is Canada's largest national cancer charity and the largest national charitable funder of cancer research in Canada.
Peer support occurs when people provide knowledge, experience, emotional, social or practical help to each other. It commonly refers to an initiative consisting of trained supporters, and can take a number of forms such as peer mentoring, reflective listening, or counseling. Peer support is also used to refer to initiatives where colleagues, members of self-help organizations and others meet, in person or online, as equals to give each other connection and support on a reciprocal basis.
Nancy Goodman Brinker is the founder of The Promise Fund and Susan G. Komen for the Cure. Brinker was also United States Ambassador to Hungary from 2001 to 2003 and Chief of Protocol of the United States from 2007 to the end of the George W. Bush administration. In 2011, she was appointed a Goodwill Ambassador for Cancer Control by the World Health Organization.
Y-ME National Breast Cancer Organization or Y-ME, was a Chicago-based national nonprofit organization that provided resources, information, and support to those suffering from breast cancer. Their mission was to "ensure, through information, empowerment and peer support, that no one faces breast cancer alone." Y-ME National Breast Cancer Organization did not fund research but did advocate for research. The organization closed in 2012, but until May of 2020, their website continued to publish various articles relating to breast cancer.
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.
Pertuzumab, sold under the brand name Perjeta, is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer.
Beckstrand Cancer Foundation is a 501(c)(3) organization that was founded in 1974 by Dr. Grant Beckstrand and a group of doctors specializing in the treatment and care of cancer patients. It was formed by incorporation as a non-profit organization.
Living Beyond Breast Cancer (LBBC), is a national 501(c)(3) nonprofit organization headquartered in Bala Cynwyd, just outside Philadelphia, Pennsylvania, in the United States. LBBC works with women who have been diagnosed with breast cancer and their caregivers throughout their experience of diagnosis, treatment and recovery. Their goal to be a "high-touch organization" that provides people with information and support of relevance to their personal experience of breast cancer. The organization supports studies of health care that are sensitive to issues of ethnicity, age, sexual orientation, and diagnosis.
Sharsheret is a nonprofit organization with the goal of supporting Jewish women diagnosed with breast cancer and ovarian cancer. Through its work and research efforts, Sharsheret provides healthcare resources, financial assistance, communal support, and educational programs to thousands of women and their families in the United States. Sharsheret has offices in California, Florida, Illinois, New Jersey and New York. They are headquartered in Teaneck, New Jersey. Sharsheret primarily works with young women and Jewish families as Ashkenazi Jews are at higher risk of carrying a BRCA gene mutation, but also aids men and women from other backgrounds.
ICanServe Foundation, Inc., formerly Information on Breast Cancer and Other Services, is a non-stock, non-profit organization that advocates early breast cancer detection through breast self-examination. Based in Manila, Philippines, and co-founded in 1999 by journalist Kara Magsanoc-Alikpala, a breast cancer survivor, the advocacy group empowers women with breast cancer and women cancer-related information so they can have a voice in their own health care. Its mission is to arm women with breast care health and breast cancer information so they can make informed decisions about their health. It also provides access to special services that will help the breast cancer survivor recover and heal more effectively.
Olaparib, sold under the brand name Lynparza, is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.
PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP).
Kara Magsanoc-Alikpala is a Philippine broadcast journalist who produces news documentaries. When diagnosed with breast cancer in 1997, she fought the disease with the help of doctors and survived. She founded the advocacy organization ICanServe which has the mission of arming "women with breast care health and breast cancer information through high impact campaigns." In addition, Magsanoc-Alikpala is the managing director of Manila-based Asianeye Productions and a contributing producer to CNN. She was selected as one of three celebrity critics for the Philippine reality-show "Dokyu". She lives and works in Manila.
Breast cancer awareness is an effort to raise awareness and reduce the stigma of breast cancer through education about screening, symptoms, and treatment. Supporters hope that greater knowledge will lead to earlier detection of breast cancer, which is associated with higher long-term survival rates, and that money raised for breast cancer will produce a reliable, permanent cure.
Ovarian Cancer Research Alliance (OCRA) is a not-for-profit organization focused on ovarian cancer research, advocacy and patient support. The organization was formed in January 2016 when the former not-for-profit organization Ovarian Cancer Research Fund, which focused primarily on ovarian cancer research, combined with Ovarian Cancer National Alliance, which focused primarily on ovarian cancer advocacy and support programs, to form one organization.
Natalie Sue Miller was an American fashion model, breast cancer survivor, breast cancer activist, counselor, and author. Born in Kansas City, Missouri, she moved to Denver, Colorado at age 19 as a newlywed and started a career in fashion modeling. After being diagnosed with breast cancer at the age of 34 and undergoing a mastectomy, she created a fashion show featuring models who had also had breast cancer. In 1981, she founded the Sue Miller Day of Caring, a non-profit organization for breast cancer education and awareness. In its first 35 years, the Day of Caring has been a resource for over 17,500 survivors of breast cancer, providing educational forums and support services at its annual event, held in nine U.S. cities. Miller earned her bachelor's and master's degrees at age 60 and 75, respectively, and wrote her autobiography, I'm Tougher Than I Look, in 2004. In 2002, Miller was inducted into the Colorado Women's Hall of Fame.
Lillie D. Shockney, RN, BS, MAS, is the University Distinguished Service Professor of Breast Cancer and Professor of Surgery and Oncology at Johns Hopkins University School of Medicine. A two-time survivor of breast cancer, Shockney works both as a nurse navigator supporting patients and as a medical advisor and administrator developing programs for improving patient quality of life, in particular for those with metastatic breast cancer. Shockney has published at least 20 books and 350 articles dealing with cancer and patient care. She has been the Editor-in-Chief of the Journal of Oncology Navigation & Survivorship (2012-2023).